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In order to understand genetic services, it is necessary first to discuss the role of
science and the role ofpublic health in genetic services. In discussing the role that
science can play in the planning and conduct of genetic services, it is necessary
to begin by asking the questions "what is science and what are the limits of
science?" There is indeed widespread misunderstanding about the meaning of
science, even among the health professionals. There are two assumptions that
are made about modern science which are incorrect and which greatly mislead
people. The first assumption is that the role of science is to collect facts and to
arrange them in order to be able to explain how the world works. Neutral,
objective scientists observe the world and may experiment with parts of it, but
they always remain detached. Provided that they follow the rules of scientific
method, their own beliefs, attitudes and desires are irrelevant to the practice of
science.' This view of science has now been widely discredited. Two major
objections to the "neutral facts" view of science are that:
(a) scientists are not detached from the world, but are part of it, so that the
very process of science carries the values, prejudices, and beliefs of
scientists and the communities in which they live;
(b) facts are a product, at least in part, of the process of searching for
them. Information becomes fact only when a scientist working within a
particular theoretical framework and using a specific methodology, creates
concepts and measurements.' In the disciplines of physics, Albert Einstein
and Niels Bohr clearly demonstrated over 75 years ago that in physics you
cannot keep the scientist out of the equation. Since that time this has been
clearly understood by theoretical physicists. In otherwords, scientists do not
escape social influence in their perceptions. In short, science is a social
process, an institution, and it must be analysed and understood as such.
It is high time that medical scientists put aside the notion that they are a group of
objective scientists who are collecting and organizing facts which are then used in
planning and delivering medical services. In the medical world there are frequent
organized meetings of "experts". Calling someone an expert is a form of sympa-
thetic magic, by giving something a name, it becomes whatthe name symbolises.
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Thus, by organizing a meeting of experts, we merely ensure that the beliefs and
assumptions of the group of experts are embodied in the recommendations.
The second assumption which is widespread among medical scientists today is
that issues in health can best be addressed by objective scientists who know the
facts. Health is all about the quality of life and science does not address issues of
quality. In other words, science cannot decide on good versus evil, nor can
science tell individuals or groups how they wish to lead their lives.2 Science
properly conducted can provide information which the people can then use to
make their own judgements about their own lives. It is important that we all
understand the above limits of science when we conduct our work in genetic
services. In other words, we certainly must use science in genetic services, but we
must use it properly.
There are two kinds of science that we will use in genetic services - clinical
science and epidemiology. What is epidemiology? This is perhaps best explained
through an analogy. Imagine a football game.3 The clinicians are the players on
the field. As such they are personally involved in the real world of action. They
are in direct contact with the ball and the other players. The clinicians know in
great detail from personal experience just exactly what is going on in the game
and they must repeatedly make quick decisions that may profoundly influence
the outcome. They talk with each other as the game progresses, making suggest-
ions, sharing experience and giving encouragement.
Then suddenly the game is half over and what happens? The players leave the
field and go to a meeting. At this meeting someone called a coach begins to
advise these players on how they should play during the second half ofthe game.
On what basis? The coach has not been on the field in actual contact with the ball
or other players. The coach has been sitting on the sideline, carefully observing
theoverall patternof play froma distance. The coach istheteam's epidemiologist.
While coaches must understand all the rules of the game, they must also have
further skills and knowledge - to know how to make correctly observations on
groups of players, how to interpret these observations, and how to communicate
them to the players in the most effective way.
During the meeting an essential, dynamic interplay takes place between the
players and the coach. The players report their experience on the field and their
impression of what is going on. The coach respects this important information
and takes it seriously, evaluating the players' reports, making an overall assess-
ment of the situation, and then advising on how to play. The players respect this
advice because of the coach's skills and unique perspective. At the same time
there is often a tension between the players and the coach. While it is hoped that
each side respectsthe other, each may also feel envious. The coach may envy the
players the excitement of participation in the action, the adrenalin surge of play,
the opportunity actually to touch the ball and make those last small but vital
judgements on which way to turn. The players may envy the coach the luxury of
sitting quietly on the sideline, not running out of breath (staying up all night), not
taking the risk of being injured (sued), and yet having so much authority and so
much to say about the course the game will take. This tension between the
players and coach may at least to some extent simply be a natural consequence
ofthe nature ofthe game and may even be constructive as long as mutual respect
remains.
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In football today, no team would want to be without a coach. Sadly we are not
there yet with health care. Some players talk only with the other players on their
own team and go to conventions where only players attend and talk (or even
brag) about their individual play. Some coaches feel superior to their players and
will not listen to them, but go to conventions attended only by coaches and talk
about the theory of the game or discuss endlessly the details of the rules of the
game. Slowly, however, it is becoming clear in health care that both the clinical
viewpoint and the epidemiological viewpoint are equally correct and valid. Both
viewpoints represent pieces ofthe truth that complement each other in a way that
brings forth the whole truth. We need players and coaches who respect and
communicate continuously with each other.
Having illustrated the epidemiological approach, now what must be said is that
the public health approach to genetic services or for that matter to any other
health services, is to combine the scientific assessment of the problem using
epidemiology with the planning, evaluation and monitoring of the health services
directed at that problem. What happens then if we apply this public health
approach to genetic services?
Genetics began as a laboratory science and, when the technology became applic-
able to humans, evolved to a combination laboratory/clinical medical specialty.
The clinical geneticist, like all clinicians, has focused on individual cases. Still
today most clinical geneticists practise differential diagnosis and treatment,
although the nature of the genetic diseases demands greater emphasis on family
history during diagnosis and greater emphasis on counselling as part of the
treatment.
Any clinical practice, including clinical genetics, is deeply influenced by the
system of health care in which the practice occurs. It doesn't take long for a new
physician in practice to discover that he is not an island unto himself but part of a
network of physicians who in turn are part of a system of services.
More recent advances in genetics are now forcing a broadening of the purely
clinical approach. For example, the possibility of preventing genetic disease,
through, for example, prenatal screening and neonatal screening has brought the
public health approach into genetic services. Screening for genetic diseases
began with neonatal screening which was quite straightforward with not too many
ethical complications. When prenatal screening came into the picture, however,
there were immediately all kinds of problems. For example, there is no use
in doing prenatal diagnosis on a pregnant woman if she would never consider
therapeutic abortion. These prenatal screening programmes have proven to
have significant false positive and false negative rates and these can be quite
devastating mistakes for a family to experience. Nevertheless, the prenatal
screening programmes have been effective and it has, forexample, been possible
completely to eliminate new cases of thallasaemia major from certain regions in
Italy where it was previously of considerable prevalence. However, elimination of
thallasaemia in Italy was only possible through extensive community education
programmes so that all of the necessary screening could be done. It is also
interesting to note that although there was a high prevalence of Catholic families
in these regions, if the need for screening for thallasaemia was explained to the
parents, there was a high rate of acceptance ofthe procedure and also a high rate
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of asking for therapeutic abortion if the prenatal diagnosis was positive. This
Italian experience is certainly relevant to the organization of genetic services in
Northern Ireland.
A new procedure offers the possibility for eliminating genetic diseases without
abortion. This is pre -implantation genetic diagnosis combined with in vitro
fertilization. There are studies going on in the UK and in the USA which illustrate
this new possibility. In both cases, couples who are known to be carriers of a
severe sex-linked genetic disease are included. In other words, the child will only
have the genetic disease if it is a male. So using IVF the egg is removed from the
woman and fertilized in vitro with the partner's sperm. When the fertilized egg
has reached the four-cell stage, one of the cells is removed and examined to
determine the gender of the fertilized egg. If it turns out to be male, the egg is
destroyed and if it turns out to be a female, the fertilized egg is re -implanted into
the woman. Since at the four-cell stage there is not yet differentiation into fetus
or placenta, it is argued that this destruction of a four-celled egg is not in fact
abortion.
But we are immediately faced by some serious problems. First of all, this
procedure demands IVF. Another epidemiologist and I carefully studied the
world's literature on IVF and found that the efficacy of this procedure was very
low - between 5 - 10% of the times one can expect to have a live baby after an
IVFcycle.4 Furthermore, thereare serious risks which havebeen markedly under-
estimated bythe clinicians involved. IVFisasad exampleof modern salesmanship
in health services. The public and the politicians have been fed a great deal of
bias, if not false information, about success rates and safety with regard to IVF.
Fortunately the Director of one IVF clinic in Northern Ireland has been actively
involved in the monitoring of IVF services in the UK.
A second problem with regard to pre-implantation genetic diagnosis is an ethical
one - where to draw the line. If we can use this procedure to eliminate serious
sex-linked genetic diseases, we can also use this procedure to eliminate female
children. As you probably know, there have already been cases in India of
couples getting prenatal diagnosis in order to eliminate any females so that they
can have a son. But where do we draw the line? Do we eliminate offspring with
crossed eyes? Even if government services have ethical controls, commercial
genetic services have few or none.
While there are a number of ethical dilemmas involved with therapeutic medicine
which arequite commonly discussed, thereare some ethical dilemmas associated
with preventive medicine and screening which are quite different and have
received very little attention.
1. Screening involves large numbers of people, so unethical decisions, whether
at a technical, clinical, social or legal level, can have widespread effects.
2. Prevention is usually addressed to healthy people, and unethical decisions
can interfere with an entirely or apparently normal life.
3. Preventive medicine and screening procedures areaimed to influence healthy
people's behaviour - to motivate them to seek genetic screening. It is likely
to reach the better educated sections of society preferentially so the issue
of equity is present. This is particularly important for genetic diseases like
( The Ulster Medical Society, 1991.
215The Ulster Medical Journal
thallasaemia and sickle cell disease which occur mostly in lower socio-
economic groups.
4. Since it involves testing large numbers of unaffected people in the search for
an affected minority, screening should be practised to the highest possible
standard with suitable training, a quality control system, and a professional
code of practice.
5. In case ofthe slighest doubt, because ofits serious and life-long implications,
agenetic diagnosis should, as faras possible, beconfirmed byanindependent
approach.
6. Results should be monitored regionally and nationally, with particular
emphasis on false-positives and false-negatives.
Thus we see the need for the public health approach in screening for genetic
diseases. One ofthe most important applications ofthe public health approach to
genetic diseases is for the rational planning of these services. Sadly it must be
pointed out that there is very little rational planning of any kind of health service
today. Very often it is only by accident that a particularservice becomes available.
If an interested clinician at a hospital wants to start a genetic clinic oran IVFclinic,
then he or she can set about doing it, but in no systemic or rational way.
In the rational planning of genetic services, the first step is to determine the need
for such service. This involves using epidemiology to determine the prevalence of
genetic diseases. For example the World Health Organization publication on
genetic services5 gives epidemiological estimates of the number of people with
certain genetic diseases in Europe. Every year in Europe 4,500 children are born
with cystic fibrosis. There are now approximately 23,000 living cystic fibrosis
individuals and it is estimated that if these same numbers continue to be born
and receive the same type ofcare now available, we will eventually have 112,000
individuals with cystic fibrosis in Europe. This illustrates that we can in fact
estimate the need for genetic services.
The second step in rational planning is to determine the ability of the present
services to meet the need that has been determined. In other words, can the
services meet the need, and if so, how well and at what cost and what danger?
There is usually very little done in any country to answer these questions. This
involves the assessment of the technology used in genetic services. In every
country in Europe there is a careful system to evaluate any new drug before it
is allowed on the market. On the other hand, a new procedure or a new machine
can be used tomorrow in any country in Europe without any necessity for its
careful assessment. As a result, many procedures and technologies come into
widespread use before any adequate assessment. The World Health Organization
did a study of routine obstetrical procedures and discovered that only about 10%
of them have been adequately scientifically evaluated as to whether or not they
are of any value.6 This is an example of the urgent need to bring good solid
scientific methodology into the assessment of what were are doing, including
genetic services.
The same holds with regard to assessment of the safety of new procedures and
technologies. Many IVF clinics advertise or state that IVF is safe, when in fact we
now know that there are all kinds of risks both to the woman and to the baby.4
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For example, the perinatal mortality rate for babies from this procedure is four
times higher than usual. We need tolook more carefully at the risks ofprocedures
and technologies and be more honest with our results. We also need to assess the
cost of procedures. This is complicated and must involve health economists in
order to include indirect costs and the costs of failures.
Once we have information on the ability of the service to meet the estimated
need, we come to the moment of decision on whether or not we want such a
service. What should be the priority for funding such a service in a health care
system and who should decide? Until recently most ofthese decisions were made
by physicians, but this is inappropriate since these are not medical decisions. No
country in the world today can afford to do everything that is possible to do with
medical procedures and technologies - transplant all ofthe hearts, dialyze all the
kidneys, give IVF to all the infertile couples. It is only the public and its represent-
atives who are in a position to make the decision with regard to who shall live.
Incidentally, the people who are suffering from a condition are not the ones who
should decide whether or not there should be services for this condition. IVF
clinicians all quote the demand for their services from infertile people. And yet
when a poll of the general public asked for priorities on how to spend money for
various medical procedures, treatment of cancer was at the top and IVF at the
bottom.7
Once a decision has been made to deliver a particular service, the next question is
how to deliver this service. Here it is necessary to involve the consumers of those
services so that they will be delivered in a way that is acceptable to the public.
Thus, to open a clinic for thallasaemia you need to approach the families with
thallasaemia in your community, and involve them actively in planning and
assessing and monitoring thisservice. Most countries haveactivelayorganizations
for the various genetic diseases and these organizations can play an important
role in determining the nature of services.
Once the services are in place, it is then necessary to have quality assurance
programmes. Whether medical people like it or not, this is the wave of the future.
Quality assurance protects the public from bad practices and also helps to be sure
that the money is well spent. One of the goals of such quality assurance is to pay
only for appropriate care. In the case of genetic diseases this would ideally get to
the point where the clinicians would be paid according to their role in reducing the
number of cases of genetic diseases. It could be that some day in the future we
will get to the ideal that was proposed by Hippocrates several thousand years ago
- that the physician should be reimbursed for all of the well people rather than
for the sick people in his practice.
It is clear from what I said that genetic services need to involve a close collabor-
ation between theclinicians, theepidemiologists, theotherpublichealth personnel
and the lay public. This is the direction that all health care is going today.
Physicians cannot make ethical decisions nor can they make priority decisions
with regard to health services. But we can use the best science to assess our
procedures and practices and then give this information totally and honestly to
the public and their representatives, so that they can decide what they would like
us to do.
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